Vanda Pharmaceuticals, Inc. (VNDA)
6.12
-1.31
(-17.63%)
USD |
NASDAQ |
Feb 12, 16:00
6.13
+0.01
(+0.16%)
After-Hours: 07:41
Vanda Pharmaceuticals Free Cash Flow : -82.95M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 6.436B |
| AbbVie, Inc. | 19.68B |
| Axsome Therapeutics, Inc. | -101.39M |
| AnaptysBio, Inc. | -145.42M |
| SELLAS Life Sciences Group, Inc. | -30.62M |
Free Cash Flow Related Metrics
| Free Cash Flow Per Share (Quarterly) | -0.5379 |
| Free Cash Flow to Equity (Quarterly) | -31.06M |
| Free Cash Flow to Firm (Quarterly) | -31.79M |
| Free Cash Flow Yield | -23.00% |